Skip to content

Shear Wave Elastography New Ultrasound Approach for the Erectile Dysfunction

a New Approach: the Use of Shear Wave Elastosonography of the Corpora Cavernosa for the Diagnosis of Erectile Dysfunction.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04399057
Enrollment
322
Registered
2020-05-22
Start date
2020-05-13
Completion date
2020-05-31
Last updated
2020-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction, Penile Diseases

Keywords

erectile dysfunction, elastosonography, penile diseases, International index of erectile function, erectile hardness score

Brief summary

the study proposes the use of a new non-invasive ultrasound method for the diagnosis of erectile dysfunction. in particular, the shear Wave elastosonosgraphy of the corpora cavernosa will be used. this last method quantitatively measures the rigidity of the analyzed tissues.

Detailed description

erectile function is a complex mechanism in which the elasticity of the tissues that make up the corpora cavernosa is fundamental. indeed, anatomopathological studies have shown that in patients with erectile dysfunction the elastic fibers are replaced by inextensible collagen. the aim of the study is the correlation between penile stiffness measured with this new non-invasive diagnostic method - elastosonography of the corpora cavernosa - and the correlation with validated questionnaires. the international Index of Erectile Function (IIEF5) short form and the erectile Hardness Score (EHS) will be used.

Interventions

DIAGNOSTIC_TESTshear Wave Elastosonography

both the left cavernous body and the right cavernous body are ideally divided longitudinally into three sections: proximal, middle and distal. subsequently for each section of the corpora cavernosa the stiffness of the tissue is calculated by means of a specific Region Of Interest (ROI). the result is expressed in Kilopascals and in a color scale. when registering the stiffness the patient is asked to hold their breath.

Sponsors

University Of Perugia
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to 80 Years

Inclusion criteria

male who came attended our general andrology clinic between January 2019 to January 2020.

Exclusion criteria

1. with: age \>80 years or \<18 years. , 2 2. diabetes, 3. spinal trauma, 4. treatment with continuous PDE5i, 5. ischemic heart disease for less than 6 months, 6. pelvic surgery for within less than 1 year, 7. hypotestosteronemia (\<8 nmol/L), 8. La Peyronie's disease. 9. penile trauma.

Design outcomes

Primary

MeasureTime frameDescription
Shear Wave elastosonografy and Erectile tissues Stiffness.15 daysuse of shear wave elastosonography for the diagnosis of erectile dysfunction by measuring the stiffness of the erectile tissue. the rigidity of the cavernous bodies is expressed in numerical values obtained in Kilopascals.
Shear Wave Elastosonography and IIEF5 questionnaire15 dayscomparison between the score in the International index of Erectile Function short form questionnaire (minimum value is 5 and maximum value is 25) and the stiffness values obtained by elastosonography with numerical absolute values obtained in kilopascals
Shear Wave elastosonography and EHS questionnaire15 dayscomparison between the score in the Erectile hardness Score questionnaire (minimum value is 0 an maximum value is 4) and the stiffness absolute values obtained by elastosonography with the numerical values obtained in kilopascals

Secondary

MeasureTime frameDescription
cut-off value at elastosonography and erectile dysfunction15 daysThe secondary objective aim of the our study is was to establish a cut-off value expressed in kilopascal to the elastosonographic Shear Wave Eelastosonography examination identifies the patient may develop erectile dysfunction due to cavernous tissue rigidity.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026